Immutep Limited (IMMP:NASDAQ) soared at $2.62, a gain of 64.8%. On Wed, May 17, 2023, IMMP:NASDAQ touched a New 2-Week High of $2.62. The stock got featured on our News Catalysts scanner on Wed, May 17, 2023 at 08:35 AM in the 'MERGER' category. From Wed, May 03, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed, May 17, 2023 at $3.9 with a volume of 77M+.
About Immutep Limited (IMMP:NASDAQ)
Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
Top 10 Gainers:
- Aspen Group, Inc. (ASPU:NASDAQ), 179.3%
- Immutep Limited (IMMP:NASDAQ), 64.78%
- Peak Bio Inc Com (PKBO:NASDAQ), 48.12%
- National Western Life Group, Inc. (NWLI:NASDAQ), 46.32%
- Smart for Life Inc. (SMFL:NASDAQ), 44.4%
- SelectQuote Inc. (SLQT:NYSE), 41.67%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 41.09%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 38.75%
- Viracta Therapeutics Inc. (VIRX:NASDAQ), 37.35%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 36.71%